AnaptysBio
ANAB
ANAB
118 hedge funds and large institutions have $990M invested in AnaptysBio in 2022 Q4 according to their latest regulatory filings, with 15 funds opening new positions, 34 increasing their positions, 38 reducing their positions, and 10 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more capital invested
Capital invested by funds: $ → $
more funds holding
Funds holding: →
more call options, than puts
Call options by funds: $ | Put options by funds: $
0.35% more ownership
Funds ownership: 115.29% → 115.64% (+0.35%)
0% more funds holding in top 10
Funds holding in top 10: 2 → 2 (0)
11% less repeat investments, than reductions
Existing positions increased: 34 | Existing positions reduced: 38
Holders
118
Holding in Top 10
2
Calls
$1.21M
Puts
$1.13M
Top Buyers
| 1 | +$11.1M | |
| 2 | +$10.8M | |
| 3 | +$9.13M | |
| 4 |
LGM
Logos Global Management
San Francisco,
California
|
+$7.75M |
| 5 |
Fidelity Investments
Boston,
Massachusetts
|
+$5.79M |
Top Sellers
| 1 | -$14.3M | |
| 2 | -$12.5M | |
| 3 | -$9.44M | |
| 4 |
DTC
Deep Track Capital
Greenwich,
Connecticut
|
-$9.18M |
| 5 |
State Street
Boston,
Massachusetts
|
-$5.29M |